Tilray reported $4.88B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 46M 39M Jun/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cronos Group USD 958.02M 45.05M Mar/2026
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.58T 118.27B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 15.73B 1.39B Mar/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025